quiz bu lëkkale ak tegtal · Dëgër Niveau
IA ci laaj ak tontu ci wàllu antibiotik
Saytu li waral antibiogram yi di ñàkk ci malaad yi, tànneef bi ci etiketu cosaan, ak xeetu bañ-bañ-prediksioŋ mënu ci jël dogal.
Laaj 1 de 8
Lan moo waral ñu yam ci antibiogramu hopitaal bi muy tegtal ci pajum empirik bu benn malaad?
Xoolaatal laaj bu nekk8 laaj
Sooy def quiz bi, tontu yi ak leeral yi dañuy feeñ.
- Lan moo waral ñu yam ci antibiogramu hopitaal bi muy tegtal ci pajum empirik bu benn malaad?
- It only lists antiviral drugs
- It is updated every hour and hard to read
- It reports hospital-wide susceptibility averages and ignores the individual's history
- It is only available after cultures return
- Ban peer moo méngoo bu baax ak njuumte bu nekk ci bind ak njëgam, ni ko tegtal bi di leeralee?
- Too narrow risks treatment failure; too broad drives resistance and C. difficile
- Too narrow causes C. difficile; too broad causes treatment failure
- Both errors only raise costs
- Neither error affects patient outcomes
- Lan mooy mébetu jëfandikoo jàngu masin ci spectre masse MALDI-TOF ci labo mikrobioloji?
- To identify the patient's blood type
- To estimate resistance hours before conventional susceptibility testing finishes
- To measure antibiotic levels in blood
- To replace the need to grow bacteria at all
- Lan moo waral xeetu bañkat yiñ tàggat ci resultaa yiñ am ci cosaan ak aada di am jafe-jafe ci wàllu tànneef?
- Cultures are only done on children
- Labs report results in different languages
- Only patients who were cultured get labels, and they are often sicker or more complex
- Resistant bacteria cannot be cultured
- Lan moo waral tegtal bi di digal ñu saytu ci diir bu gàtt ngir xeetu bañkat yi?
- Resistance patterns and CLSI or EUCAST breakpoints change over time
- It makes models train faster
- Regulators forbid random splits
- Older data is always more accurate
- Which decision can a resistance-prediction model NOT make, according to the guide?
- Which drug is likely to be ineffective
- The probability of MRSA
- The narrowest drug likely to work
- Whether the patient needs antibiotics at all, such as telling true infection from asymptomatic bacteriuria
- In prospective audit and feedback, what happens?
- Pharmacists or infectious disease physicians review active prescriptions and recommend changes
- Patients rate their antibiotics after discharge
- Drugs are blocked until a lab result arrives
- Software automatically cancels all broad-spectrum orders
- What did the 2020 Kanjilal study on outpatient urinary tract infections report?
- The algorithm eliminated the need for urine cultures
- Tested retrospectively, the algorithm could reduce second-line antibiotic use while keeping ineffective therapy similar to or lower than clinicians' choices
- Clinicians refused to use the algorithm in a randomized trial
- The algorithm increased resistance rates